“Potential role of interleukin 28B-gene polymorphism and natural immune enhancer treatment response in chronic HCV patients”, J Biochem Microbiol Biotechnol, vol. 3, no. 1, pp. 15–20, Oct. 2015, doi: 10.54987/jobimb.v3i1.230.